The worsening of the glycemic status among the diabetes cohort required changes in their diabetes management, where half (58.9%) of diabetics were started on insulin therapy, 66 (17.1%) required an increase in their original dose of insulin therapy, and 178 (46%) converted from oral hypoglycemic agents to insulin therapy to allow for better glucose level control upon discharge. The gene discussed is INS; the disease is diabetes mellitus.